The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Abstract

Objective:

This study examined long-term outcomes (at 36 months) from Washington State’s policy of expediting Medicaid enrollment for prison releasees with severe mental illness and compares them with previously reported short-term outcomes (at 12 months).

Methods:

Linked administrative data on prison releasees (2006–2007) were analyzed by using a quasi-experimental design comparing those referred to expedited Medicaid (N=895) with a control group of those not referred (N=2,189). Aggregate outcomes were analyzed with inverse probability of treatment–weighted logit models.

Results:

Expedited Medicaid had a sustained effect on both increased months of enrollment (p<.01) and increased use of community mental health and general medical services (p<.01) 36 months after prison release. However, expedited Medicaid did not reduce criminal recidivism, consistent with 12-month findings,

Conclusions:

Outcome results at 12 months were sustained at 36 months—namely, expedited Medicaid for released prisoners with severe mental illness improved enrollment and service use with no effects on criminal recidivism.

The United States has the largest prison population in the world, with over 2.2 million people incarcerated in prisons and jails in 2014 (1). Estimates of the percentage of inmates who have a severe mental illness range from 8% to 20% of the prison population (1,2). Not only are those with severe mental illness disproportionately represented in the criminal justice system, they are also more likely to reoffend than prisoners without severe mental illness (3). Because Medicaid is the single largest payer for mental health services for those with severe mental illness (2,4), enrollment upon release is crucial for access to care, but most individuals lose their Medicaid benefits during incarceration and thus are not enrolled in Medicaid when they are released (5).

In 2006, Washington State began a program to expedite enrollment in Medicaid prior to release from prison for persons with severe mental illness, which is discussed in detail elsewhere (6). Our previous research on persons released from prison with severe mental illness compared those referred to expedited Medicaid with those not referred and found that expediting increased Medicaid enrollment and use of mental health services but had no effect on criminal recidivism over a 12-month follow-up period (7). We speculated that the absence of a recidivism effect might be attributable to insufficient time for treatment to have an effect. To assess this delayed-effects hypothesis, we extended the follow-up period of our previous research from 12 to 36 months after release from prison to examine longer-term outcomes for Medicaid enrollment, mental health care service use, and criminal recidivism.

Methods

We used the same linked administrative data from Washington State agencies as in our prior work (6,7). We extended the person-specific file to encompass 36-month follow-up data derived from Medicaid, the Department of Social and Health Services (general medical and mental health service use), and Department of Corrections. We also used the same quasi-experimental design to compare prisoners with severe mental illness released in 2006–2007 who were referred for expedited Medicaid (N=895) with released prisoners with severe mental illness who were not referred for expedited Medicaid (N=2,189).

Because of concerns about referral selection bias, we used inverse probability of treatment weights (IPTW) (propensity scores) to balance treatment and comparison groups on 50 baseline observable factors reflecting prior criminal justice contacts, use of mental health services and medication, and other factors. Data were analyzed at the person level with IPTW generalized linear models with a logit link for a series of binary outcomes, which included the use of a variety of public programs and services during a 36-month postrelease follow-up period. Specifically, we examined the use of outpatient mental health care, general medical care, emergency department services, and inpatient general medical use. We also examined outcomes on criminal recidivism. We looked at outcomes at 12 months, between 13 and 24 months, between 25 and 36 months, and cumulatively over 36 months to investigate whether there was a lagged effect of expedited Medicaid.

As reported previously, except for the use of state psychiatric hospital inpatient services, use of general medical services is detected only through enrollment in public programs, such as Medicaid, or service provision by government agencies or facilities; thus service use may be confounded with Medicaid participation. As a result, these measures are robust from a government payer perspective but may underestimate service use supported by private providers and charity.

The research was conducted with the approval of institutional review boards at the Washington State Department of Social and Health Services and the University of North Carolina at Chapel Hill.

Results

By 36 months postrelease, 89% of those referred for expedited Medicaid enrollment were enrolled in Medicaid, whereas only 62% of the comparison group were enrolled, with an adjusted between-group difference of 22.0 percentage points (p<.01) (Table 1). This difference was approximately 8 percentage points lower than the difference in enrollment at 12 months, suggesting that over time, although Medicaid enrollment increased in the control group, the expedited group still maintained a wide enrollment advantage.

TABLE 1. Outcomes at 12 and 36 months among Washington State prisoners released with severe mental illness and referred or not referred (control) to expedited Medicaid

Unweighted mean in expedited group (N=895)Unweighted mean in control group (N=2,189)Average effect of expedited Medicaid from propensity score analysis (percentage points)
Outcome and follow-upN%N%
Medicaid enrollment
 By 12 months723819424330.1**
 By 36 months794891,3476222.0**
Use of community services
 Any use of outpatient general medical care
  By 12 months574649174216.2**
  By 36 months713801,4116510.9**
 Any emergency department use
  By 12 months488557713514.9**
  By 36 months613691,2155610.3**
 Any use of inpatient general medical care
  By 12 months1051219091.6
  By 36 months21224400183.6
 Any use of outpatient mental health treatment
  By 12 months618698093726.2**
  Between 13 and 24 months454517423413.2**
  Between 25 and 36 months37842673317.6**
  Over 36 months (cumulative)721811,2355619.9**
Criminal justice contacts
 Any arrests
  By 12 months531591,190544.1
  By 36 months653731,60373–.0003
 Any Department of Corrections days
  By 12 months495551,008466.3**
  Between 13 and 24 months41146815376.5**
  Between 25 and 36 months28031573264.0*

*p<.05, **p<.01

TABLE 1. Outcomes at 12 and 36 months among Washington State prisoners released with severe mental illness and referred or not referred (control) to expedited Medicaid

Enlarge table

Consistent with our prior findings at 12 months following release, the expedited group had higher rates of community mental health service use at 36 months (p<.01). The rate of outpatient mental health treatment over 36 months (cumulative) was almost 20 percentage points higher in the expedited group, but the rate trended down from the 12-month outcomes, when it was 26 percentage points higher in the expedited group (p<.01). Importantly, from 12 to 36 months postrelease, both groups had substantially declining treatment rates, measured in annual increments; however, treatment rates declined faster from 12 to 36 months in the expedited group than in the comparison group (from 69% to 42% in the expedited group versus from 37% to 31% in the comparison group).

The adjusted rate of use of outpatient general medical care was nearly 11 percentage points higher in the expedited Medicaid group than in the comparison group at 36 months, a decrease from a 16–percentage point difference between groups at 12 months postrelease (p<.01). The adjusted rate of emergency department use was 10 percentage points higher in the expedited group at 36 months postrelease, whereas at the 12-month follow-up, the adjusted difference was nearly 15 percentage points (p<.01). Consistent with 12-month findings, no significant difference in use of inpatient general medical care was observed between groups at 36 months.

At 36 months, cumulative arrest rates were the same (73%) for both expedited and control groups, a no-difference finding first observed at 12 months. This result was similar in magnitude and significance when we examined the subgroup of prison stays at 36 months that were for technical violations rather than for new crimes (data not reported). In contrast, the expedited group had a higher rate of Department of Corrections days than the control group at 12 months (55% versus 46%, p<.01), 24 months (46% versus 37%, p<.01), and 36 months (31% versus 26%, p<.05). The adjusted between-group differences remained consistent and significant in the 4%–6% range at each follow-up point, although the risk of incarceration declined for both groups by about 43% over the 36-month period.

Discussion

The effect of the expedited Medicaid program on enrollment in Medicaid and use of community health services from 12 to 36 months for released prisoners with severe mental illness remained large and significant. This finding suggests that rapid enrollment in the Medicaid program upon release led to long-term, sustained increases in insurance coverage and in the amount of community services utilized. However, the effect of expedited Medicaid on Medicaid enrollment narrowed from 12 to 36 months, because of the comparison group’s proportionately larger gains in Medicaid enrollment during this period through efforts unrelated to the expedited Medicaid policy. Despite this narrowing effect, expedited Medicaid had long-lasting and significant positive effects. This sustained effect over three years is striking given that the reduction in un-insurance between the groups as a result of the expedited Medicaid intervention occurred in the first three months postrelease.

As might be expected, the rapid enrollment in Medicaid among offenders in the expedited Medicaid program was associated with a larger difference in use of mental health services in the first year postrelease, with a declining difference in the following two years. The declining differences were almost entirely in the intervention group, whose use of mental health services dropped from 69% in year 1 to 42% in year 3, while use by the comparison group stayed relatively constant over this period, with about a third of enrollees using mental health services. These rates seem low for both groups, given the diagnosis of severe mental illness, especially because most individuals in both the treatment and the comparison groups had Medicaid coverage.

Uncontrolled selection bias may have continued to have an impact on the effects on Medicaid coverage and health service use; perhaps those identified for expedited Medicaid were sicker and had more externalizing symptoms. However, given the large number of control variables from the preincarceration period included in the analyses, this seems unlikely. Furthermore, the higher rate of use of the emergency department in the expedited group is consistent with results found in the Oregon Health Insurance Experiment, in which random assignment to Medicaid coverage led to a statistically significant increase in the number of emergency department visits over an 18-month period (8).

Criminal recidivism outcomes at 36 months were similar to the previous findings at 12 months postrelease (7). Both groups experienced high rearrest rates, reaching 73% cumulatively at 36 months, with no significant difference between the expedited and comparison groups. The second indicator of recidivism, Department of Corrections days, showed a higher rate for the expedited group than for the control group at 12 months, a finding that mirrors results previously reported. However, the new insight from this 36-month analysis is that this difference persisted in each of the following two years, albeit at a decreasing rate. In other words, individuals in the expedited group were not arrested any more often than those in the control group, but those in the expedited group spent more time on average in prison each year after arrest compared with those in the control group. This is an unexpected finding that runs counter to our lagged-effects hypothesis that use of general medical and behavioral health treatment would decrease the risk of incarceration over time. In contrast, an earlier analysis by Washington State, and one of the few other empirical studies to address this relationship, found that chemical dependency treatment use by low-income adults was associated with a decrease in the risk of arrest (9). However, that analysis focused on a different, community-based, higher-functioning sample than the prison releasees with severe mental illness considered in this study.

Clearly, further research is required to determine the underlying causes of prolonged prison stays for individuals referred for expedited Medicaid. It is likely that Medicaid alone is only part of the solution to high rates of arrest and incarceration of persons with severe mental illness. Interventions that address housing, employment, social relationships, substance abuse, and mental health functioning are also needed to reduce recidivism (1012). Moreover, several cognitive-behavioral interventions are now being used or adapted for justice-involved persons with mental illness, and these interventions address the criminogenic risk factors associated with justice involvement more directly than does Medicaid (13,14).

As with our earlier analyses, some limitations must be considered when interpreting these results. This study used data solely from Washington State, and findings may not be generalizable to states with different Medicaid programs, varying populations with severe mental illness, and dissimilar prison populations. The data may have omitted risk factors for criminal justice and other outcomes that are correlated with expedited treatment, despite the use of a large group of baseline covariates. Information about community health service use was generated through use of administrative data from government payer programs, and thus it did not reflect use of services in the nonpublic sector, although prior research has shown that privately funded health service use in a population with severe mental illness is low (6,7). In addition, because we used administrative data to measure community-based health care service use, this measure may be confounded with our measure of Medicaid coverage for some outcomes.

Conclusions

Consistent with our 12-month findings, expediting Medicaid on release from incarceration significantly increased use of mental health and general medical services but did not reduce criminal recidivism among released prisoners with severe mental illness during a 36-month follow-up period.

Ms. Grabert, Mr. Gertner, Dr. Domino, and Dr. Morrissey are with the Department of Health Policy and Management, Gillings School of Global Public Health, and Dr. Cuddeback is with the School of Social Work, University of North Carolina, Chapel Hill. The authors are also with the Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill.
Send correspondence to Ms. Grabert (e-mail: ).

This research was supported in part by grant R01-MH086232 from the National Institute of Mental Health.

The findings and interpretations reported here are those of the authors and do not imply endorsement by Washington State agencies.

The authors report no financial relationships with commercial interests.

The assistance of staff at the Washington State Department of Social and Health Services and the Washington State Department of Corrections in data retrieval, linkage, and documentation is gratefully acknowledged.

References

1 Kaeble D, Glaze L, Tsoutis A, et al: Correctional Populations in the United States, 2014. Washington, DC, US Department of Justice, Bureau of Justice Statistics, 2015. https://www.bjs.gov/content/pub/pdf/cpus14.pdfGoogle Scholar

2 Morrissey JP, Dalton KM, Steadman HJ, et al.: Assessing gaps between policy and practice in Medicaid disenrollment of jail detainees with severe mental illness. Psychiatric Services 57:803–808, 2006LinkGoogle Scholar

3 Skeem JL, Louden JE: Toward evidence-based practice for probationers and parolees mandated to mental health treatment. Psychiatric Services 57:333–342, 2006LinkGoogle Scholar

4 Mark TL, Yee T, Levit KR, et al.: Insurance financing increased for mental health conditions but not for substance use disorders, 1986–2014. Health Affairs 35:958–965, 2016CrossrefGoogle Scholar

5 Rosen DL, Dumont DM, Cislo AM, et al.: Medicaid policies and practices in US state prison systems. American Journal of Public Health 104:418–420, 2014Crossref, MedlineGoogle Scholar

6 Cuddeback GS, Morrissey JP, Domino ME: Enrollment and service use patterns among persons with severe mental illness receiving expedited Medicaid on release from state prisons, county jails, and psychiatric hospitals. Psychiatric Services 67:835–841, 2016LinkGoogle Scholar

7 Morrissey JP, Domino ME, Cuddeback GS: Expedited Medicaid enrollment, mental health service use, and criminal recidivism among released prisoners with severe mental illness. Psychiatric Services 67:842–849, 2016LinkGoogle Scholar

8 Taubman SL, Allen HL, Wright BJ, et al.: Medicaid increases emergency-department use: evidence from Oregon’s Health Insurance Experiment. Science 343:263–268, 2014Crossref, MedlineGoogle Scholar

9 Mancuso D, Felver BEM: Providing Chemical Dependency Treatment to Low-Income Adults Results in Significant Public Safety Benefits. Olympia, Washington State Department of Social and Health Services, Research and Data Analysis Division, 2009Google Scholar

10 Visher C, Travis J: Transitions from prison to community: understanding individual pathways. Annual Review of Sociology 29:89–113, 2003CrossrefGoogle Scholar

11 Bonta J, Law M, Hanson K: The prediction of criminal and violent recidivism among mentally disordered offenders: a meta-analysis. Psychological Bulletin 123:123–142, 1998Crossref, MedlineGoogle Scholar

12 Andrews DA, Bonta J, Wormith JS: The recent past and near future of risk and/or need assessment. Crime and Delinquency 52:7–27, 2006CrossrefGoogle Scholar

13 Golden L: Evaluation of the Efficacy of a Cognitive Behavioral Program for Offenders on Probation: Thinking for a Change. Washington, DC, National Institute of Corrections, 2002. http://www.nicic.org/pubs/2002/018190.pdfGoogle Scholar

14 Little GL, Robinson KD: Moral reconation therapy: a systematic step-by-step treatment system for treatment resistant clients. Psychological Reports 62:135–151, 1988Crossref, MedlineGoogle Scholar